Breaking News

NexPoint Acquires Mfg. Property for Kindeva Drug Delivery

R&D facility has clinical manufacturing and lab space offering a range of capabilities to support drug delivery solutions.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NexPoint, an investment firm, launched NexPoint Life Sciences III DST, a Delaware Statutory Trust, which acquired a life sciences industrial manufacturing property in Woodbury, MN. The DST expects to raise approximately $31 million through the offering. The 138,000-square-foot property is the global headquarters for Kindeva Drug Delivery, a contract development and manufacturing organization (CDMO) that develops and manufactures products across a range of complex drug-delivery formats. The pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters